Replies to post #198177 on Avid Bioservices Inc (CDMO)

[edcpf]

I like your post and open-mindedness.

I do not agree that the company responds only to latest trends though. It's been a long way and lots of hard work to understand how PS-targeting works in immunotherapy. Similarly, getting that government grant for Ebola can be a very big plus in validating the platform.

What I do agree with is that CJ's and ES's backgrounds are probably in the worst 5 percentile what we could have, and that's a valid reason to be pissed.

I do not agree with SK's and others' raises, however I support SK, JS, JH, RG, SF, SW, etc., the KOLs (RB), and even PL, providing validation comes and the science delivers not later than on a material event associated with the second SUNRISE look-in.